Checkpoint inhibition is a form of cancer immunotherapy that blocks proteins used by cancer cells to evade detection by the immune system, thereby enabling T-cells to recognize and attack tumors. This approach has revolutionized cancer treatment, showing significant success in treating various types of cancers, such as melanoma and lung cancer.